18 Month Analysis of Macular Structure using Optical Coherence Tomography (OCT) from a Phase 1/2 Clinical Study of Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa

AGTC-501 - AGTC

https://arvo2022.arvo.org/meetings/zMkzkWfJmG38zfsGA

Paul Yang; Andreas Lauer; Mark Pennesi; David Birch; Rand Spencer; Robert Sisk; Alessandro Iannaccone; Matthew Feinsod; Mauro Goldbaum

Apr 29, 2022